Yannick Bulliard

Company: Appia Bio

Job title: Senior Director - Research

Seminars:

Armored HSC-derived CAR-iNKT Cells as a Differentiated Platform for Targeting Solid Tumors 1:00 pm

Discuss the engineering of hematopoietic stem cells to derive highly efficacious CAR- and iTCR-expressing iNKT cells Establish a robust manufacturing process to provide differentiated allogeneic cell therapies for difficult-to-treat solid tumor indications Explore the muti-functional mechanisms of action of CAR-iNKT cells, including modification of immunosuppressive cells of the tumor microenvironmentRead more

day: Day One Track A AM